Very important update for $NVO stockholders
What’s happening with Novo Nordisk stock?
What does the stock expect in 2026?
And why do I still strongly bet on Novo Nordisk despite all the negative numbers?
The weight loss drug market in America is growing very rapidly, but over the past two years, Eli Lilly has managed to significantly outperform Novo Nordisk and take a large market share due to major issues faced by Novo in supply chains and manufacturing shortages.
Even the FDA temporarily allowed the entry of compound drugs that mimic Novo’s medications due to supply shortages, which led to
View Original